AVN-397
id:
avn-397-239-6981100
title:
AVN-397
text:
AVN-397 is a 5-hydroxytryptamine subtype 6 receptor antagonist drug developed by Avineuro Pharmaceuticals Inc. that can potentially be used to treat Alzheimer's disease and general anxiety disorder (GAD). Avineuro announced that it would start Phase II clinical trials in 2009, and those trials are ongoing as of 2012.
brand slug:
wiki
category slug:
encyclopedia
description:
Drug possibly to treat Alzheimer's disease
original url:
https://en.wikipedia.org/wiki/AVN-397
date created:
date modified:
2023-11-07T01:00:48Z
main entity:
{"identifier":"Q117312468","url":"https://www.wikidata.org/entity/Q117312468"}
image:
fields total:
13
integrity:
14